Symposia
LGBTQ+
Trevor A. Hart, Ph.D. (he/him/his)
Toronto Metropolitan University
Toronto, Ontario, Canada
Graham Berlin, MA (he/him/his)
PhD Student
Toronto Metropolitan University, Department of Psychology
Toronto, Ontario, Canada
Yangqing Deng, PhD (he/him/his)
postdoctoral fellow
University Health Network.
Toronto, Ontario, Canada
Syed Noor, PhD
Professor
Louisiana State University Shreveport
Shreveport, Louisiana, United States
Paolo Palma, PhD (he/him/his)
postdoctoral fellow
Toronto Metropolitan University
Toronto, Ontario, Canada
Shayna Skakoon-Sparling, Ph.D. (she/her/hers)
Postdoctoral Research Fellow
Toronto Metropolitan University, Department of Psychology
Toronto, Ontario, Canada
Jeffrey Wardell, Ph.D.
Assistant Professor
York University
Toronto, Ontario, Canada
Sarah Dermody, Ph.D., C.Psych (she/her/hers)
Associate Professor
Toronto Metropolitan University
Toronto, Ontario, Canada
Darrell Tan, MD, FRCPC, PhD (he/him/his)
Research Director, Clinician Scientist
St. Michael’s Hospital
Toronto, Ontario, Canada
Daniel Grace, PhD
Assistant professor
University of toronto
Toronto, Ontario, Canada
Nathan Lachowsky, PhD (he/him/his)
Associate Dean, Associate Professor
University of Victoria
Victoria, Ontario, Canada
Joseph Cox, MD
Associate Professor
McGill University
Montreal, Quebec, Canada
David Moore, MDCM, MHSc
Research Scientist
University of British Columbia and Centre for Excellence in HIV/AIDS
Vancouver, British Columbia, Canada
Gilles Lambert, MD
Medical Consultant
Direction regionale de sante publique
Montreal, Quebec, Canada
Terri Zhang, BSc (they/them/theirs)
Research Coordinator
Toronto Metropolitan University
Toronto, Ontario, Canada
Milada Dvorakova, MS
Research Assistant
McGill University Health Centre
Montreal, Quebec, Canada
Allan Lal, BA
Momentum Research Coordinator
BC Centre of Excellence in HIV/AIDS
Vancouver, British Columbia, Canada
Jody Jollimore, MPH (he/him/his)
executive director
Canadian AIDS Treatment Information Exchange (CATIE)
Toronto, Ontario, Canada
Compared to gay, bisexual, and other men who have sex with men (GBM) who do not use crystal methamphetamine (CM), GBM reporting CM use have greater odds of acquiring bacterial sexually transmitted infections (STI). However, heterogeneity in frequency, urges/desire to use, and substance use-related problems exists among GBM who use CM. We examined whether CM use and symptoms are associated with differences in sexual attitudes, behaviors, and health outcomes, in order to identify points of intervention. We used baseline data (n=2449) from the Engage Cohort Study, a community-recruited sexual health study of GBM in Vancouver, Toronto, and Montreal. We examined the Alcohol, Smoking and Substance Involvement Screening Test for CM-using GBM (ASSIST-CM) scale, STI-related psychosocial and behavioral measures, anxiety and depression, and nurse-administered testing for HIV and other STIs. Using the ASSIST-CM, we identified distinct patterns of CM use using Latent Class Analysis (LCA). We then included variables that differed among classes in bivariate analyses in a multinomial regression model to examine associations with class membership. A 4-class solution fit the data best: Class 1, occasional users without reported concerns and problems; Class 2, occasional users with reported concerns and attempts to stop/control use; Class 3, monthly users with consequences; and Class 4, weekly users with frequent consequences. In the multinomial regression, we found class differences in education, city, alcohol use, sexual compulsivity, and escape motives. GBM living with HIV were more likely to be in Class 4 than in other groups. Injection drug use differed between each class, with Class 3 >Class 4 >Class 2 >Class 1. Our analysis illustrates the diversity in patterns of CM use among GBM and underscores the importance of integrating tailored substance use counseling and treatments with STI risk reduction and sexual health promotion among different classes of CM-using GBM.